Ncardia is a pioneering biotechnology company specializing in human induced pluripotent stem cell (iPSC) technology to support drug discovery and regenerative medicine. With over 15 years of experience, Ncardia provides high-quality iPSC products, relevant screening assays, and custom services to enhance the clinical success of therapeutic developers. The company has established a strong market position by serving 17 of the top 20 global pharmaceutical companies and supporting over 150 iPSC-based therapeutic projects. Ncardia's innovative approach and commitment to quality make it a trusted partner for drug innovators aiming to accelerate the development of new therapies.
Something looks off?